Microbix Biosystems Inc., a life science company, develops and commercializes proprietary biological and technological solutions for human health and wellbeing in North America, Europe, and internationally. The company manufactures a wide r…
Sign in to search companies, open filing PDFs, fetch uncached SEDAR+ documents, and use the
full company research view.
Ownership 2026-05-28
Marino, Martin bought +$56k
Insider trading – 2026-05-28
1 insider · +$56k net
Ownership 2026-05-26
Costa, Daniel Oliveira bought +$1k
Insider trading – 2026-05-26
1 insider · +$1k net
Results 2026-05-14
Interim MD&A - English.pdf
Results 2026-05-14
Interim financial statements/report – English.pdf
Results 2026-05-07
Microbix Schedules Release of Results for Q2 Fiscal 2026
News release - English.pdf
News 2026-04-27
Microbix Product Results Being Presented at 2026 PASCV
News release - English.pdf
News 2026-04-20
Microbix Engages with Diagnostics Industry Experts Releasing Episodes of Season Two of “Diagnostics: Beyond the Lab” Podcast
News release - English.pdf
News 2026-04-16
Microbix Presenting at the 2026 Bloom Burton Conference
News release - English.pdf
News 2026-04-15
Microbix Exhibiting & Presenting at ESCMID Global 2026
News release - English.pdf
News 2026-03-17
Microbix Presents Reference-Material Innovations at EUROGIN
News release - English.pdf
Results 2026-02-12 Financials
Interim MD&A - English.pdf
Results 2026-02-12 Financials
Interim financial statements/report – English.pdf
News 2026-02-10
Microbix Welcomes The College of American Pathologists as a Client For Supply of QAPs for PT/EQA Programs
News release - English.pdf
News 2026-02-04
Microbix Presents Molecular Pathology Platform Results Novel Quality Controls to Enable QC & Inter-Laboratory Standardization
News release - English.pdf
News 2026-01-07
Microbix Commercializes SARS-CoV-2 (COVID) Recombinant Antigen For Usage in QAPs and Test Manufacturing
News release - English.pdf
Results 2025-12-18 Financials
Annual information form - English.pdf
Results 2025-12-18 Financials
Audited annual financial statements (amended) - English.pdf
Results 2025-12-18
Microbix Reports Results for Q4 and Fiscal 2025
News release - English.pdf
Results 2025-12-18 Financials
Audited annual financial statements – English.pdf
Results 2025-12-18 Financials
Annual MD&A - English.pdf
News 2025-12-10
Microbix Launches New Products to Support H3N2 Flu Testing
News release - English.pdf
Results 2025-12-04 Returns
Microbix Announces Initiation of Normal Course Issuer Bid For Repurchase of up to 5% of its outstanding shares over 12 months
News release (section 4.8 of NI 62-104).pdf
News 2025-12-03
Microbix & Seegene Mexico Collaborate to Improve Test Accuracy
News release - English.pdf
News 2025-11-12
News release - English.pdf
News 2025-11-05
News release - English.pdf
News 2025-09-25
News release - English.pdf
News 2025-09-23
News release - English.pdf
News 2025-09-17
News release - English.pdf
News 2025-09-03
News release - English.pdf
News 2025-08-14
News release - English.pdf
Results 2025-08-14 Financials
Interim MD&A - English.pdf
Results 2025-08-14 Financials
Interim financial statements/report – English.pdf
News 2025-08-07
News release - English.pdf
News 2025-07-29
News release - English.pdf
News 2025-07-24
News release - English.pdf
News 2025-07-08
News release - English.pdf
News 2025-06-17
News release - English.pdf